Key Takeaways
- EN 14476 compliance plays an important role when you are planning to launch virucidal disinfectant products to medical and healthcare markets
- Testing protocol evaluates the products against both enveloped ( like vaccinia virus) and non-enveloped viruses such as Poliovirus, Adenovirus, and Murine Norovirus).
- EN 14476 uses a quantitative suspension test (phase 2 step 1 test) in which disinfectants are tested against target viruses in suspension.
- To meet EN 14476 passing criteria, a product needs to demonstrate a minimum 4 log reduction under standard test conditions
- EN 14487 compliance helps to understand product efficacy and support antiviral marketing claims and regulatory submission.
Summary
Meeting EN 14476 compliance helps to ensure that your disinfectant product is able to prove virucidal activity against target strains with a minimum 4 log reduction. It is applicable to products used across healthcare, medical and general hygiene settings. Aligning with efficacy criteria stipulated in EN 14476 helps manufacturers achieve regulatory acceptance, support accurate marketing claims, and avoid risk of delays.
What is EN 14476?
EN14476 is a European standard that specifies the quantitative suspension test method for evaluating the virucidal activity of chemical disinfectants that are planned to be used in the medical area. This standard gives necessary test requirements and efficacy criteria for checking the ability of disinfectants to eliminate viruses effectively including enveloped viruses like SARS-CoV-2 virus responsible for COVID-19.
What is the importance of EN 14476 compliance?
If you are planning to launch a disinfectant product with virucidal claims, then it is required to have efficacy proof. EN 14476 testing is one of the widely accepted standards used to substantiate claims within the European regulatory framework.
If products claiming virucidal properties and fail to comply with recognised testing standards, it can lead to following problems –
- Substantiating virucidal claims for marketing purposes
- Gaining regulatory acceptance in European markets
- Building trust in healthcare and hygiene applications
Industries that require EN 14476 compliance
EN 14476 is applied across areas where disinfection is medically indicated. This includes medical settings such as hospitals, nursing homes, school based health clinics, etc.
Products commonly get tested under EN 14476 include surface disinfectants, hygienic hand rubs and hand washes, instrument disinfectants, textile disinfectants and similar products
Test methodology principle
EN 14476 is a (phase 2 step 1) quantitative suspension test.
Disinfectant sample is added to virus suspension in the presence of an interfering substance. The test mixture is maintained for specific contact times and under controlled temperature conditions.
After contact time, the disinfectant action is neutralized and the remaining virus infectivity in the neutralized sample is assessed using cell culture techniques. Product’s virucidal efficacy is determined by comparing the reduction in viral titre from the test sample with control.
Products must achieve at least a 4 log reduction in virus count to pass EN 14476 testing.
Step-by-Step process for EN 14476 certification
Step 1: Understand standard requirements
The first step is to have a thorough understanding of the test requirements and efficacy criteria under EN 14476 standard. This includes detailed information on target viruses, test methods, intended application areas, and minimum passing criteria.
The product manufacturer should be well versed with this information and have clarity if their developed product falls within the scope of testing specified by EN 14476 standard.
Step 2: Finding a certified laboratory for testing
The next crucial step is to find a well equipped and certified laboratory that is competent for testing the virucidal efficacy of the product as per EN 14476 standard. In simple words, choosing the right lab ensures the accuracy and reliability of results.
Step 3: Document submission
Once the product meets the passing criteria, test reports and other product-related documents should be compiled and submitted to a certification body that deals with EN14476 standards. Documentation includes test results, product formulations, safety data sheets, and any other relevant information.
Step 4: Certification audit if applicable
Some products may require a certification audit. As a part of the process, the certifying body will review the product, the manufacturing process, and the test data reports to ensure full compliance with EN 14476 standards.
Step 5: Receive certification and maintain compliance
Upon successful audit and review, the product is ready for EN 14476 certification.
What can go wrong in EN 14476 compliance and how to avoid it
Even well formulated products can fail EN 14476 due to following issues –
Wrong virus selection for intended claims – This happens when the viruses used in testing don’t actually support what you are claiming for. For instance, you are testing against a few viruses but claiming broad virucidal activity.
Ignoring real-use conditions – If testing is done only under clean conditions, the test results will not reflect real virucidal strength of your product. Stringent test conditions are critical specifically when your products are made for high risk environments such as hospitals.
Incorrect concentration or dilution of product sample during testing – The disinfectant sample should be tested at the exact concentration and conditions intended for actual use. If testing doesn’t match actual usage instructions, the results will not support your label claims.
Incomplete documentation – Even when testing is done correctly, unstructured data and any missing details in the test report can create problems for manufacturers. Make sure that the result data is clear, concise and backing up your claims.
Late stage testing – Testing only at the final stage can result in costly reformulations if the product fails to meet the required log reduction. So, plan testing alongside formulation development
Quick tips for manufacturers
- Align your product claims with real test conditions
- Conduct tests in both clean and dirty environments.
- To prevent repeat testing or delays, plan testing in advance.
- Collaborate closely with experienced laboratories
- Prepare paperwork for approvals and audits.
FAQs
Do I need EN 14476 testing for my disinfectant product?
EN 14476 testing is generally required if your product is designed to make virucidal claims within European regulatory frameworks.
What does 4 log reduction mean in EN 14476?
A 4 log reduction simply means that disinfectant is able to reduce viral infectivity by at least 99.99% compared to the initial level.
Can EN 14476 test results be used for marketing claims?
Yes, EN 14476 results can support marketing claims, but only when those claims accurately reflect the required passing criteria outlined in EN 14476 standard.
What types of disinfectant products can be tested under EN 14476?
The standard applies to chemical disinfectants and antiseptic products, including hygiene hand washes, hand rubs, surface disinfectants, instrument disinfectants and products used for textile disinfection.
What happens if my product fails EN 14476 testing?
If it fails, the product cannot support virucidal claims. You may need to reformulate, adjust concentration, or modify contact time, and then repeat testing.
When should I conduct EN 14476 testing during product development?
Testing should be done after finalizing the formulation, but ideally after initial screening. This avoids repeated failures and reduces cost during development.
Can one EN 14476 test cover all types of viruses?
It is important to note that EN 14476 only covers the viruses specified within its test guidelines. It follows defined test conditions and target strains under which the product is evaluated.
How do I choose the right laboratory for EN 14476 testing?
Choose a laboratory that has proven experience with EN standards and understands regulatory requirements for disinfectant testing.
